human
papillomaviru
hpv
oncogen
mucosainfect
etiolog
agent
caus
case
cervic
cancer
world
genom
hpv
consist
three
region
viz
noncod
region
extend
control
nonstructur
structur
region
open
read
frame
briefli
protein
atpdepend
dna
helicas
involv
replic
protein
act
regul
viral
gene
transcript
genom
replic
protein
involv
earli
late
phase
viru
life
cycl
immun
modul
protein
involv
cell
differenti
target
numer
neg
regul
cell
cycl
tumor
suppressor
gene
assemblag
protein
capsom
result
format
icosahedr
capsid
around
viral
genet
materi
format
progeni
identif
antigen
determin
crucial
vaccin
develop
cytotox
lymphocyt
ctl
also
known
killer
cell
cell
matur
thymu
specif
primari
lymphoid
organ
human
immun
system
cell
play
vital
role
cellmedi
immun
respons
invad
intracellular
foreign
substanc
like
virus
addit
cell
peptid
cell
present
major
histocompat
complex
mhc
class
ii
locat
antigenpres
cell
apc
trigger
immun
respons
therefor
cell
also
known
helper
th
cell
initi
apc
identifi
pathogenassoci
molecular
pattern
tolllik
receptor
tlr
result
cleavag
antigen
small
fragment
mhc
class
ii
peptid
complex
activ
naiv
th
cell
trigger
mediat
cellular
immun
respons
b
cellmedi
humor
immun
respons
interestingli
antigen
complex
mhc
class
directli
result
mediat
cellular
immun
respons
detect
ctl
epitop
stimul
immun
respons
play
critic
role
individu
immun
system
current
avail
prophylact
vaccin
gardasil
gardasil
could
provid
protect
women
induc
signific
immun
vaccin
limit
age
year
howev
prophylact
vaccin
demonstr
therapeut
benefit
patient
alreadi
hpv
infect
us
food
drug
administr
fda
center
diseas
control
prevent
cdcp
recommend
hpv
vaccin
safe
caus
pain
uneasi
sore
guillainbarr
syndrom
patient
howev
control
preval
rate
highgrad
hpv
infect
speciesspecif
screen
vaccin
need
type
hpv
highrisk
hpv
hrhpv
type
induc
uncontrol
cell
growth
cervix
uteri
region
identifi
among
report
major
strain
caus
cervic
cancer
around
world
fact
contribut
hrhpv
type
limit
due
geograph
distribut
member
alpha
papillomavirida
famili
speci
moreov
preval
rate
case
cervic
cancer
found
high
vari
record
differ
geograph
region
ghana
portug
serbia
spain
pakistan
usa
japan
burkina
faso
northern
part
china
southeast
region
brazil
northeast
india
differ
host
genet
framework
oncogen
circul
variant
might
play
critic
role
geograph
distribut
togeth
highli
record
case
squamou
cell
carcinoma
adenocarcinoma
case
invas
cervic
cancer
cervic
intraepitheli
neoplasia
grade
base
level
enrich
cervic
cancer
case
compar
women
normal
cytolog
featur
suggest
third
highest
oncogen
agent
next
comparison
hrhpv
type
limit
report
exist
peptid
research
immunogen
peptid
one
excel
resourc
develop
therapeut
vaccin
hrhpv
strain
instant
access
open
databas
informat
tool
suggest
effici
method
develop
vaccin
reduc
time
labor
experiment
cost
sever
studi
report
virtual
peptid
oncoprotein
effici
induc
immun
respons
cervic
cancer
patient
reveal
peripher
blood
mononuclear
cell
sampl
howev
crossprotect
hrhpv
strain
could
ignor
crossreact
ctl
peptid
suspect
play
essenti
role
produc
immun
respons
multipl
strain
select
immunogen
epitop
whole
genom
hrhpv
strain
may
enabl
design
novel
ctl
vaccin
therefor
identifi
potenti
immunogen
overlap
bcell
epitop
antigen
protein
anticip
epitop
pool
capabl
demonstr
immunogen
respons
hrhpv
strain
workflow
studi
illustr
figur
whole
amino
acid
sequenc
genom
retriev
uniprot
knowledgebas
uniprotkb
databas
amino
acid
sequenc
complet
list
nonstructur
structur
protein
includ
sequenc
replic
initi
protein
regulatori
protein
major
capsid
protein
minor
capsid
protein
obtain
octob
biolog
target
therapi
submit
manuscript
wwwdovepresscom
overlap
epitop
hpv
total
sequenc
protein
extract
includ
alignmentindepend
vaxijen
tool
employ
determin
antigen
complet
list
select
sequenc
protect
antigen
score
calcul
base
auto
crosscovari
acc
transform
protein
sequenc
normal
vector
essenti
amino
acid
properti
jj
l
denot
acc
n
number
amino
acid
sequenc
amino
acid
posit
l
lag
index
j
use
z
scale
antigen
score
protein
predict
respect
threshold
valu
addit
method
follow
overlap
epitop
predict
ctl
epitop
netctl
server
employ
predict
ctl
epitop
input
sequenc
integr
predict
pi
score
ctl
epitop
presenc
mhc
ligand
obtain
result
threshold
valu
sensit
specif
set
ctl
epitop
predict
immun
epitop
databas
iedb
combin
tool
use
predict
process
antigen
mhc
class
antigen
process
present
pathway
netmhc
artifici
neural
network
ann
use
find
natur
potenti
proteasom
cleavag
transport
associ
antigen
process
tap
transport
mhc
class
bind
ctl
epitop
fiftyon
frequent
occur
mhc
class
allel
includ
human
leukocyt
antigen
hla
hlab
hlac
hlae
select
input
tap
transport
predict
peptid
length
alpha
factor
defin
threshold
mhc
class
allel
show
bind
affin
ic
nm
select
use
studi
select
evalu
tcell
epitop
immunogen
optim
mhc
class
peptid
determin
use
tcell
class
pmhc
immunogen
predict
tool
base
properti
posit
amino
acid
within
peptid
immunogen
mhc
peptid
predict
use
follow
formula
denot
immunogen
score
peptid
ligand
l
present
hla
molecul
h
everi
posit
p
ligand
l
log
enrich
score
e
amino
acid
posit
l
p
weight
import
posit
p
sum
mask
anchor
posit
hla
present
analysi
first
second
ctermin
amino
acid
mask
method
follow
overlap
epitop
epitop
conserv
analysi
tool
use
find
degre
conserv
epitop
within
set
given
protein
sequenc
given
ident
level
set
sequenc
epitop
e
protein
p
given
input
degre
conserv
percentag
e
within
p
estim
fraction
p
match
align
e
chosen
ident
level
conserv
analysi
perform
structur
nonstructur
protein
sequenc
hrhpv
strain
iedb
pc
tool
use
calcul
pc
predict
ctl
epitop
calcul
fraction
individu
predict
respond
epitop
set
base
hla
genotyp
frequenc
mhc
bind
tcell
restrict
data
provid
allel
frequenc
differ
ethnic
countri
assembl
differ
geograph
area
number
epitop
set
epitop
mhcrestrict
allel
mhc
class
select
popul
area
select
per
user
choic
analysi
predict
peptid
structur
homolog
model
use
predict
chemic
structur
select
antigen
protein
hidden
markov
model
suboptim
conform
sampl
approach
appli
predict
structur
input
peptid
sequenc
confirm
simul
run
select
differ
cluster
model
sort
sopep
energi
iter
thread
assembl
refin
itass
use
predict
threedimension
structur
target
receptor
protein
model
analysi
engin
use
highli
innov
remot
homolog
detect
method
accur
construct
structur
target
within
durat
minut
hour
itass
anoth
vital
protein
structur
predict
tool
identifi
respect
structur
templat
protein
data
bank
pdb
local
metathread
server
lomet
fulllength
atom
model
creat
repetit
templat
fragment
patchdock
tool
employ
shape
represent
surfac
patch
match
filter
score
base
rank
elit
peptid
model
select
dock
target
prepar
hla
molecul
use
dock
predict
epitop
result
refin
firedock
server
accord
energi
function
final
refin
full
interfac
side
chain
optim
atom
radiu
facilit
decreas
number
conflict
bind
interact
dock
structur
evalu
use
ucsf
chimera
highli
extens
program
interact
visual
data
shown
predict
identif
epitop
overlap
bcell
epitop
predict
interferongamma
produc
tcell
epitop
iedb
consensu
method
use
predict
tcell
epitop
combin
follow
neural
network
align
net
mhcii
stabil
matrix
method
align
comblib
sturniolo
method
iedb
comprehens
dataset
consist
unpublish
mhc
peptid
bind
affin
crystal
structur
experiment
proven
peptid
major
popul
tool
hladrb
locu
consist
allel
subtyp
select
analysi
result
lowest
percentil
rank
peptid
exhibit
higher
bind
affin
antigen
present
apc
receptor
th
cell
th
cell
produc
activ
moreov
mhc
class
iirestrict
epitop
analyz
use
ifn
epitop
tool
predict
program
use
motifbas
model
support
vector
machin
hybrid
algorithm
show
accuraci
predict
epitop
dataset
consist
mhc
class
ii
binder
bcell
epitop
select
antigen
sequenc
predict
use
abcpr
tool
result
predict
base
experiment
train
bcell
epitop
dataset
abcpr
first
server
creat
base
recurr
neural
network
ie
jordan
network
machinebas
techniqu
use
fixedlength
pattern
accuraci
evalu
select
overlap
epitop
allergenfp
essenti
tool
predict
allergen
peptid
sequenc
base
novel
descriptor
fingerprint
approach
accuraci
specif
sensit
contain
allergen
nonallergen
amino
acid
segment
analysi
crossreact
human
proteom
similar
analysi
perform
find
epitop
match
human
proteom
use
integr
open
databas
protein
inform
resourc
peptidematch
program
system
biologybas
virtual
cancer
pathway
predict
kinet
literatur
survey
perform
collect
requir
inform
select
protein
sequenc
design
predict
peptid
involv
biochem
pathway
mathemat
comput
model
entir
infect
signal
pathway
interact
specif
gene
presenc
peptid
develop
visual
use
celldesign
model
tool
node
pathway
repres
entiti
edg
repres
connect
one
node
anoth
close
relat
inhibitori
concentr
propos
peptid
collect
publish
experiment
data
pharmacokinet
studi
mass
action
kinet
appli
pharmacokinet
studi
time
cours
kinet
simul
perform
concern
transit
time
cancer
complet
tabl
ctl
epitop
total
ctl
epitop
predict
earli
protein
late
protein
base
mhc
class
supertyp
netctl
threshold
valu
among
epitop
ctl
epitop
show
higher
bind
affin
ic
nm
mhc
class
allel
found
use
netmhc
ann
tabl
depict
proteasom
score
tap
score
mhc
score
process
score
total
score
bind
affin
predict
epitop
differ
allel
determin
use
netmhc
ann
accord
result
epitop
protein
atdtgsdmv
present
find
epitop
found
immunogen
list
immunogen
epitop
structur
nonstructur
protein
illustr
tabl
design
epitopebas
vaccin
use
conserv
epitop
may
help
provid
broader
protect
across
multipl
strain
develop
crossreact
vaccin
tabl
show
detail
result
conserv
analysi
immunogen
epitop
posit
protein
subsequ
respect
crossprotect
hrhpv
strain
conserv
immunogen
epitop
across
hrhpv
strain
shown
figur
overlap
epitop
hpv
overlap
epitop
hpv
note
ctl
predict
netctl
threshold
b
predict
netmhc
ann
proteasom
cleavag
score
interpret
logarithm
total
amount
cleavag
site
usag
liber
peptid
cterminu
tap
score
estim
effect
log
ic
valu
bind
tap
peptid
ntermin
prolong
precursor
mhc
bind
predict
score
ident
class
log
ic
valu
process
score
combin
proteasom
cleavag
tap
transport
predict
predict
quantiti
proport
amount
peptid
present
endoplasm
reticulum
peptid
bind
multipl
mhc
molecul
total
score
combin
proteasom
cleavag
tap
transport
mhcbind
predict
predict
quantiti
proport
amount
peptid
present
mhc
molecul
cell
surfac
abbrevi
ctl
cytotox
lymphocyt
hla
human
leukocyt
antigen
hpv
human
papillomaviru
mhc
major
histocompat
complex
tap
transport
associ
antigen
process
biolog
target
therapi
submit
manuscript
wwwdovepresscom
kaliamurthi
et
al
america
cumul
pc
achiev
around
world
figur
overlap
epitop
hpv
mhc
class
iirestrict
epitop
product
highrank
mhc
class
ii
epitop
lower
percentil
valu
capac
illustr
tabl
among
highrank
epitop
overlap
potenti
immunogen
tcell
epitop
region
highlight
bold
total
bcell
epitop
amino
acid
length
predict
nand
ctermin
region
note
firedock
rigid
bodi
score
energi
bestrank
solut
number
global
energi
attract
repuls
van
der
waal
energi
atom
contact
energi
hydrogen
bond
energi
peptid
mhc
receptor
protein
complex
b
amino
acid
residu
peptid
mhc
receptor
protein
dock
complex
initi
distanc
hydrogen
bond
donor
acceptor
analyz
chimera
abbrevi
ac
atom
contact
avdw
attract
van
der
waal
hb
hydrogen
bond
hla
human
leukocyt
antigen
mhc
major
histocompat
complex
rvdw
repuls
van
der
waal
biolog
target
therapi
submit
manuscript
wwwdovepresscom
overlap
epitop
hpv
v
f
f
p
h
f
p
f
k
n
g
n
p
n
overlap
epitop
tabl
illustr
epitop
sequenc
posit
select
protein
allergen
antigen
immunogen
effici
tcell
epitop
overlap
bcell
epitop
select
epitop
found
immunogen
among
epitop
identifi
nonallergen
antigen
threshold
valu
addit
epitop
effici
induc
product
similar
level
zero
indic
uniqu
match
queri
epitop
found
homo
sapien
taxonomi
id
moreov
peptid
would
elimin
risk
induc
autoimmun
disord
predict
peptid
inhibit
trigger
signal
pathway
mapk
pathway
overexpress
downregul
tumor
suppressor
transcript
repressor
gene
multifunct
regul
gene
myc
tumor
suppressor
prb
higher
express
minichromosom
mainten
protein
prolifer
cell
nuclear
antigen
protein
antigen
altern
read
frame
protein
mdm
gene
involv
uncontrol
cell
divis
viru
immort
mapk
pathway
apoptosi
notch
pathway
transcript
telomeras
revers
transcript
figur
gene
pathway
activ
involv
develop
hpv
caus
cervic
cancer
includ
cervic
intraepitheli
neoplasia
invas
cervic
carcinoma
result
figur
indic
concentr
entiti
time
differ
color
second
time
cours
simul
entiti
constant
result
indic
propos
peptid
could
work
best
anticanc
peptid
inhibit
variou
pathway
involv
cervic
cancer
develop
kinet
simul
also
perform
use
differ
concentr
overlap
epitop
hpv
peptid
crossvalid
result
obtain
concentr
support
literatur
inform
time
cours
kinet
simul
predict
demonstr
biolog
behavior
presenc
peptid
interact
differ
molecul
play
import
role
cervic
cancer
inhibit
hpv
infect
sole
respons
cervic
cancer
case
fitzmauric
et
al
report
agestandard
incid
death
rate
cervic
cancer
develop
develop
countri
exploit
bioinformat
techniqu
led
emerg
concept
advanc
vaccin
design
differ
diseas
immunoinformat
approach
play
vital
role
qualit
screen
multipl
genom
predict
target
epitop
provid
ration
design
enhanc
tcell
immun
respons
costeffect
manner
possibl
antigen
identif
molecular
level
enabl
sensibl
design
peptid
vaccin
advantag
epitopebas
vaccin
potenti
induc
high
dosag
immunogen
lower
cost
therefor
present
studi
aim
predict
potenti
immunogen
epitop
whole
genom
strain
design
epitopebas
vaccin
vaxijen
first
server
develop
predict
antigen
protein
virus
bacteria
fungi
parasit
tumor
cell
potenti
antigen
classif
complet
base
physicochem
properti
protein
relat
sequenc
align
therefor
util
vaxijen
tool
present
studi
predict
potenti
antigen
protein
accuraci
reliabl
predict
ctl
epitop
vital
consist
drug
develop
receptor
consist
singl
chain
furthermor
ctl
identifi
epitop
present
mhc
class
establish
nucleat
cell
process
facilit
bind
conserv
region
mhc
class
recent
elut
studi
bassanisternberg
et
al
prove
peptid
natur
optim
antigen
process
process
result
support
present
studi
mhc
class
ipres
peptid
synthes
endogen
process
pathwayderiv
protein
predict
potenti
mhc
class
irestrict
epitop
base
endogen
process
pathway
proteasom
cleavag
tap
transport
mhc
class
bind
algorithm
use
combin
method
iedb
mhc
class
contain
peptidebind
domain
immunoglobulinlik
domain
transmembran
region
heavi
chain
mhc
class
molecul
code
gene
hla
b
c
loci
mhc
gene
highli
polymorph
natur
mean
residu
nand
ctermin
region
mhc
protein
could
gener
cleft
specif
peptid
bind
mhc
class
allel
exhibit
broader
bind
specif
peptid
amino
acid
high
promiscu
neural
network
base
comput
approach
play
vital
role
predict
bind
affin
peptid
specif
mhc
molecul
present
studi
ftfphafpf
cvsywgvyy
ltaevmsyi
fsdpsiiev
antigen
epitop
found
interact
number
hla
allel
specif
highbind
affin
absolut
desir
effici
epitop
vaccin
develop
greatli
depend
extent
interact
hla
allel
moreov
activ
cell
kill
target
three
crucial
mechan
includ
secret
antitumor
antivir
substanc
membran
disrupt
granulysin
fasmedi
kill
recent
studi
report
preval
rate
multipl
hrhpv
genotyp
cervic
cancer
poor
surviv
rate
associ
invas
cervic
carcinoma
moreov
hrhpv
strain
coinfect
shown
increas
death
rate
hiv
patient
conserv
epitop
provid
power
immun
prolong
period
sabah
et
al
found
singl
ctl
epitop
etsvheiel
conserv
protein
isol
design
epitopebas
vaccin
use
conserv
epitop
may
help
provid
broader
crossprotect
across
multipl
strain
present
studi
demonstr
immunogen
epitop
show
crossprotect
hrhpv
clifford
et
al
report
invas
cervic
cancer
rate
higher
africa
europ
highest
grade
cervic
cancer
lesion
also
record
asia
latin
america
moreov
cervic
cancer
second
fatal
cancer
contribut
cancer
indian
women
american
cancer
societi
estim
case
invas
uterin
cervic
cancer
agestandard
incid
rate
cervic
cancer
overal
geograph
region
china
around
kaliamurthi
et
al
find
show
highest
pc
pool
epitop
record
europ
north
america
west
indi
west
indi
north
africa
east
asia
northeast
asia
west
africa
south
asia
southwest
asia
southeast
asia
oceania
east
africa
central
africa
south
america
central
america
south
africa
pc
find
show
peptid
vaccin
would
effect
immun
huge
popul
extens
geograph
region
lack
scientif
report
bind
cleft
interact
epitop
hla
molecul
consid
fact
bind
affin
potenti
immunogen
epitop
receptor
hlaa
hlab
hlac
analyz
use
dock
tool
notabl
prophylact
vaccin
hpv
protein
use
treat
hpv
infect
countri
present
studi
found
strong
bind
affin
predict
epitop
ltaevmsyi
three
differ
mhc
class
allel
hlaa
moreov
studi
report
multiepitop
vaccin
enhanc
clearanc
hpvposit
cancer
mous
model
tacin
vaccin
synthes
singl
fusion
protein
clinic
phase
studi
healthi
volunt
show
signific
product
confirm
tcell
immun
respons
patient
present
studi
minor
capsid
protein
fsdpsiiev
epitop
show
affin
peptidebind
groov
allelespecif
pocket
mhc
class
hlaa
hlaa
hlaa
hlac
allel
case
epitop
rtevyqfaf
show
potenti
bind
interact
hlaa
hlab
highest
global
bind
energi
kcal
mol
respect
moreov
violent
regul
extrachromosom
replic
protein
express
virus
addit
protein
hrhpv
caus
apoptosi
hpvtransform
cell
compar
lowrisk
hpv
strain
present
find
epitop
ftfphafpf
exhibit
excel
affin
peptidebind
groov
allelespecif
pocket
mhc
class
hlaa
hlab
hlac
allel
epitop
cvsywgvyy
exhibit
excel
affin
mhc
class
hlaa
allel
mhc
class
ii
molecul
share
superfici
similar
bind
peptid
howev
vital
differ
exist
mhc
class
ii
molecul
cap
natur
mhc
class
peptidebind
groov
allelespecif
pocket
allow
variat
length
peptid
call
regist
shift
peptidebind
groov
mhc
class
molecul
close
end
contrast
peptidebind
groov
mhc
class
ii
molecul
open
end
allow
bind
extend
peptid
rang
aa
length
sercarz
maveraki
report
longer
peptid
peptideflank
residu
lie
outsid
peptidebind
groov
mhc
class
ii
molecul
might
interact
peptid
anoth
distal
locat
mhc
class
ii
protein
primarili
present
peptid
deriv
endocytosi
extracellular
protein
exogen
process
pathway
present
studi
promis
epitop
predict
consensu
approach
late
earli
protein
predict
epitop
possess
good
bind
affin
lowest
percentil
rank
mhc
class
ii
allel
immun
respons
associ
product
furthermor
epitop
found
use
machin
learn
hybrid
method
b
cellmedi
humor
immun
involv
recognit
antigen
circul
bodi
fluid
recent
paolini
et
al
report
product
lymphocyt
induc
anticanc
vaccin
carri
whole
gene
multiepitop
preclin
cancer
model
bristo
et
al
report
immun
singl
peptid
contain
ctl
epitop
ie
mhc
class
irestrict
peptid
nest
within
epitop
elicit
respons
product
cell
anim
model
also
predict
overlap
epitop
within
ideal
bcell
cell
epitop
region
result
suggest
nest
bcell
epitop
may
elicit
ctlinduc
cellular
immun
cellinduc
adapt
immun
b
cellmedi
humor
immun
identifi
epitop
may
substanti
implic
peptid
vaccinebas
immunotherapi
hpv
type
immunolog
distinct
necessari
find
suitabl
target
develop
therapeut
vaccin
conclud
predict
nest
linear
bcell
epitop
possibl
induc
cellmedi
humor
immun
ctl
cell
b
cell
virusinfect
host
system
moreov
epitop
protein
potenti
effect
use
develop
uniqu
crossprotect
biolog
target
therapi
submit
manuscript
wwwdovepresscom
overlap
epitop
hpv
peptid
vaccin
hrhpvattribut
cervic
cancer
howev
experiment
peptid
sensit
studi
need
confirm
find
humor
cellmedi
immun
respons
overlap
epitop
may
enabl
design
novel
peptidebas
therapeut
vaccin
improv
effici
better
protect
